Page last updated: 2024-10-25

deferoxamine and Osteopetrosis

deferoxamine has been researched along with Osteopetrosis in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Osteopetrosis: Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Key, LL1
Ries, WL1
Glasscock, H1
Rodriguiz, R1
Jaffe, H1

Other Studies

1 other study available for deferoxamine and Osteopetrosis

ArticleYear
Osteoclastic superoxide generation: taking control of bone resorption using modulators of superoxide concentrations.
    International journal of tissue reactions, 1992, Volume: 14, Issue:6

    Topics: Animals; Bone Resorption; Culture Techniques; Deferoxamine; Free Radical Scavengers; Humans; Interfe

1992